Search Results - "Zhao, Qinying"
-
1
Meta-Analysis of the Relationship between Abdominal Obesity and Diabetic Kidney Disease in Type 2 Diabetic Patients
Published in Obesity facts (01-08-2021)“…Abstract Background and Objectives: The meta-analysis aimed to investigate the association of visceral fat area (VFA), waist circumference (WC), waist-hip…”
Get full text
Journal Article -
2
The link between self-uncertainty and conspicuous consumption: Tolerance of uncertainty as a moderator
Published in Frontiers in psychology (09-01-2023)“…This study, based on self-affirmation theory, aims to investigate the impact of self-uncertainty on individual consumption behavior. Self-uncertainty was…”
Get full text
Journal Article -
3
Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma
Published in Frontiers in genetics (23-09-2022)“…Background: Cancer-associated fibroblasts (CAFs) are an essential cell population in the pancreatic cancer tumor microenvironment and are extensively involved…”
Get full text
Journal Article -
4
Being Negatively Cued, are People Less Cooperative? The Influence of Watching Eyes on Cooperative Behavior
Published in Evolutionary psychology (01-10-2022)“…In the course of human evolution, watching eyes have had an important influence on individual cooperative behavior. However, researchers have not explored how…”
Get full text
Journal Article -
5
Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review
Published in Frontiers in endocrinology (Lausanne) (20-06-2022)“…The clinical manifestation of hepatocyte nuclear factor-1-alpha ( HNF1-alpha ) maturity-onset diabetes of the young (MODY) is highly variable. This study aims…”
Get full text
Journal Article -
6
PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma
Published in Biochemistry and biophysics reports (01-03-2024)“…Cancer growth is significantly influenced by processes such as pyroptosis, apoptosis, and necroptosis that underlie PANoptosis, a proinflammatory programmed…”
Get full text
Journal Article -
7
Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa
Published in PloS one (18-11-2016)“…Malaria remains one of the most important causes of morbidity and mortality in pregnant women and their newborn babies in sub-Saharan Africa. Intermittent…”
Get full text
Journal Article -
8
Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease: A Phase I, Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study
Published in Clinical neuropharmacology (2013)“…Ponezumab is a humanized antiamyloid beta (Aβ) monoclonal antibody designed to treat Alzheimer disease (AD). This randomized, double-blind,…”
Get full text
Journal Article -
9
Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
Published in Alzheimer's & dementia : translational research & clinical interventions (01-09-2017)“…Abstract Introduction Multiple intravenous doses of ponezumab, an anti-amyloid antibody, were evaluated in subjects with mild-to-moderate Alzheimer's disease…”
Get full text
Journal Article -
10
Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease
Published in Clinical neuropharmacology (2013)“…Ponezumab (PF-04360365) is a humanized anti-amyloid beta (Aβ) monoclonal antibody designed for treatment of Alzheimer disease (AD). A single 2-hour intravenous…”
Get full text
Journal Article -
11
Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study
Published in International journal of clinical pharmacology and therapeutics (01-12-2013)“…PF-04360365 is a humanized IgG(2)Δa anti-amyloid β (Aβ) antibody designed to improve outcome in Alzheimer's disease (AD). Single doses of 0.1 - 10 mg/kg were…”
Get full text
Journal Article -
12
1745-P: IPO13 Maintains Glucose Homeostasis by Regulating Insulin Secretion and α-Cell Expansion
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction & Objective: Importin 13 (IPO13) is a member of IPOβ family and is one of only three mammalian IPO proteins able to mediate both import and export…”
Get full text
Journal Article -
13
Pharmacokinetic and Safety Assessments of Galantamine and Risperidone after the Two Drugs Are Administered Alone and Together
Published in Journal of clinical pharmacology (01-12-2002)“…To explore the steady‐state pharmacokinetic profile after coadministration of galantamine and risperidone, an open‐label, randomized, single‐center, two‐way…”
Get full text
Journal Article -
14
Constructing Pd and Cu Crowding Single Atoms by Protein Confinement to Promote Sonogashira Reaction
Published in Advanced materials (Weinheim) (01-09-2024)“…For multicenter‐catalyzed reactions, it is important to accurately construct heterogeneous catalysts containing multiple active centers with high activity and…”
Get full text
Journal Article -
15
Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes
Published in Diabetes (New York, N.Y.) (01-10-2021)“…Perirenal fat is adjacent to kidneys and active in metabolism and adipokine secretion. We aimed to investigate whether perirenal fat is an independent…”
Get full text
Journal Article -
16
Pharmacokinetics and Safety of Galantamine in Subjects with Hepatic Impairment and Healthy Volunteers
Published in Journal of clinical pharmacology (01-04-2002)“…The objective of this study was to compare the pharmacokinetics and safety of galantamine in subjects with hepatic impairment with those in healthy subjects…”
Get full text
Journal Article -
17
Pharmacokinetic and Safety Assessments of Concurrent Administration of Risperidone and Donepezil
Published in Journal of clinical pharmacology (01-02-2003)“…Treatment of Alzheimer's disease sometimes uses combinations of drugs because dementia is frequently associated with behavioral symptoms. Risperidone and…”
Get full text
Journal Article -
18
U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors
Published in Clinical cancer research (15-09-2020)“…Taletrectinib (DS-6051b/AB-106) is an oral, tyrosine kinase inhibitor of ROS1 and NTRK with potent preclinical activity against G2032R solvent-front mutation…”
Get full text
Journal Article -
19
Pharmacokinetics of Intravenous Itraconazole followed by Itraconazole Oral Solution in Patients with Human Immunodeficiency Virus Infection
Published in Journal of clinical pharmacology (01-12-2001)“…This randomized, open‐label, comparative study assessed the pharmacokinetics and safety of intravenous and oral hydroxypropyl‐β‐cyclodextrin (HP‐β‐CD)…”
Get full text
Journal Article -
20
Triglyceride-Glucose Index Levels Positively Associated with Higher Risk of Low Muscle Mass in Patients with Type 2 Diabetes
Published in Diabetes, metabolic syndrome and obesity (30-09-2024)“…Although the interplay of insulin resistance (IR) and low muscle mass is increasingly recognized, it remains unknown whether the triglyceride-glucose (TyG)…”
Get full text
Journal Article